BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 28458337)

  • 41. Prolonged zona glomerulosa insufficiency causing hyperkalemia in primary aldosteronism after adrenalectomy.
    Fischer E; Hanslik G; Pallauf A; Degenhart C; Linsenmaier U; Beuschlein F; Bidlingmaier M; Mussack T; Ladurner R; Hallfeldt K; Quinkler M; Reincke M
    J Clin Endocrinol Metab; 2012 Nov; 97(11):3965-73. PubMed ID: 22893716
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of kidney function with residual hypertension after treatment of aldosterone-producing adenoma.
    ; Wu VC; Chueh SC; Chang HW; Lin LY; Liu KL; Lin YH; Ho YL; Lin WC; Wang SM; Huang KH; Hung KY; Kao TW; Lin SL; Yen RF; Chen YM; Hsieh BS; Wu KD
    Am J Kidney Dis; 2009 Oct; 54(4):665-73. PubMed ID: 19628318
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Systematic review of the clinical outcomes of mineralocorticoid receptor antagonist treatment versus adrenalectomy in patients with primary aldosteronism.
    Satoh M; Maruhashi T; Yoshida Y; Shibata H
    Hypertens Res; 2019 Jun; 42(6):817-824. PubMed ID: 30948836
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Change in kidney function after unilateral adrenalectomy in patients with primary aldosteronism: identification of risk factors for decreased kidney function.
    Kim IY; Park IS; Kim MJ; Han M; Rhee H; Seong EY; Lee DW; Lee SB; Kwak IS; Song SH; Chung HC
    Int Urol Nephrol; 2018 Oct; 50(10):1887-1895. PubMed ID: 29779118
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chronic kidney disease score for predicting postoperative masked renal insufficiency in patients with primary aldosteronism.
    Tanase-Nakao K; Naruse M; Nanba K; Tsuiki M; Tagami T; Usui T; Okuno H; Shimatsu A; Hashimoto S; Katabami T; Ogo A; Okumura A; Umakoshi H; Suzuki T
    Clin Endocrinol (Oxf); 2014 Nov; 81(5):665-70. PubMed ID: 24821606
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recent progress in the diagnosis and treatment of primary aldosteronism.
    Yoshida Y; Shibata H
    Hypertens Res; 2023 Jul; 46(7):1738-1744. PubMed ID: 37198444
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Renal cysts and hypokalemia in primary aldosteronism: results of long-term follow-up after treatment.
    Novello M; Catena C; Nadalini E; Colussi GL; Baroselli S; Chiuch A; Lapenna R; Bazzocchi M; Sechi LA
    J Hypertens; 2007 Jul; 25(7):1443-50. PubMed ID: 17563567
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of primary aldosteronism: Clinical practice guidelines of the Taiwan Society of Aldosteronism.
    Tseng CS; Chan CK; Lee HY; Pan CT; Peng KY; Wang SM; Huang KH; Tsai YC; Wu VC; Chueh JS;
    J Formos Med Assoc; 2024 Mar; 123 Suppl 2():S125-S134. PubMed ID: 37328332
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Endothelial progenitor cells in primary aldosteronism: a biomarker of severity for aldosterone vasculopathy and prognosis.
    Wu VC; Lo SC; Chen YL; Huang PH; Tsai CT; Liang CJ; Kuo CC; Kuo YS; Lee BC; Wu EL; Lin YH; Sun YY; Lin SL; Chen JW; Lin SJ; Wu KD;
    J Clin Endocrinol Metab; 2011 Oct; 96(10):3175-83. PubMed ID: 21816781
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prolonged postoperative hypoaldosteronism related to hyperkalemia in patients with aldosterone-producing adenoma.
    Wada N; Baba S; Sugawara H; Miyoshi A; Obara S
    Endocr J; 2023 Sep; 70(9):917-924. PubMed ID: 37423737
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Incidental and Intentional Medicine Achieve Similar Results in Primary Hyperaldosteronism.
    Kuo LE; Wachtel H; Roses RE; Fraker DL; Kelz RR
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S734-41. PubMed ID: 26193964
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hypokalemia and the Prevalence of Primary Aldosteronism.
    Gruber S; Beuschlein F
    Horm Metab Res; 2020 Jun; 52(6):347-356. PubMed ID: 32252108
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Outcomes of drug-based and surgical treatments for primary aldosteronism.
    Steichen O; Lorthioir A; Zinzindohoue F; Plouin PF; Amar L
    Adv Chronic Kidney Dis; 2015 May; 22(3):196-203. PubMed ID: 25908468
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preoperative masked renal damage in Japanese patients with primary aldosteronism: identification of predictors for chronic kidney disease manifested after adrenalectomy.
    Utsumi T; Kawamura K; Imamoto T; Nagano H; Tanaka T; Kamiya N; Nihei N; Naya Y; Suzuki H; Ichikawa T
    Int J Urol; 2013 Jul; 20(7):685-91. PubMed ID: 23190329
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Markers of Kidney Tubular Function Deteriorate While Those of Kidney Tubule Health Improve in Primary Aldosteronism After Targeted Treatments.
    Wu VC; Chan CK; Chueh JS; Chen YM; Lin YH; Chang CC; Lin PC; Chung SD;
    J Am Heart Assoc; 2023 Feb; 12(4):e028146. PubMed ID: 36789834
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preoperative mineralocorticoid receptor antagonist reduces postoperative hyperkalaemia in patients with Conn syndrome.
    Zhang J; Libianto R; Lee JC; Grodski S; Shen J; Fuller PJ; Yang J
    Clin Endocrinol (Oxf); 2022 Jan; 96(1):40-46. PubMed ID: 34743353
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Renin as a Biomarker to Guide Medical Treatment in Primary Aldosteronism Patients. Findings from the SPAIN-ALDO Registry.
    Parra Ramírez P; Martín Rojas-Marcos P; Paja Fano M; González-Boillos M; Pascual-Corrales E; García Cano AM; Ruiz-Sanchez JG; Vicente Delgado A; Gómez Hoyos E; Ferreira R; García Sanz I; Recasens Sala M; Barahona San Millan R; Picón César MJ; Díaz Guardiola P; Perdomo CM; Manjón-Miguélez L; Rebollo Román Á; Robles Lázaro C; Morales-Ruiz M; Calatayud M; Andree Furio Collao S; Meneses D; Sampedro-Nuñez MA; Mena Ribas E; Sanmartín Sánchez A; Gonzalvo Diaz C; Lamas C; Guerrero-Vázquez R; Del Castillo Tous M; Serrano Gotarredona J; Michalopoulou Alevras T; Tenés Rodrigo S; Roa Chamorro R; Jaen Aguila F; Moya Mateo EM; Hanzu FA; Araujo-Castro M
    High Blood Press Cardiovasc Prev; 2024 Jan; 31(1):43-53. PubMed ID: 38225508
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Insufficiency of the zona glomerulosa of the adrenal cortex and progressive kidney insufficiency following unilateral adrenalectomy - case report and discussion.
    Kanarek-Kucner J; Stefański A; Barraclough R; Gorycki T; Wolf J; Narkiewicz K; Hoffmann M
    Blood Press; 2018 Oct; 27(5):304-312. PubMed ID: 29742971
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diagnosis and treatment of primary aldosteronism.
    Rossi GP
    Endocrinol Metab Clin North Am; 2011 Jun; 40(2):313-32, vii-viii. PubMed ID: 21565669
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Assessment of postoperative renal function after adrenalectomy in patients with primary aldosteronism.
    Onohara T; Takagi T; Yoshida K; Iizuka J; Okumi M; Kondo T; Ishida H; Tanabe K
    Int J Urol; 2019 Feb; 26(2):229-233. PubMed ID: 30384394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.